Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
USANA Health Sciences, Inc. (USNA) had Consolidated Net Income/Loss of $6.96M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$250.22M |
|
$7.51M |
|
$59.44M |
|
$190.78M |
|
$236.34M |
|
$13.87M |
|
$1.59M |
|
$15.46M |
|
$15.46M |
|
$6.96M |
|
$6.96M |
|
|
Consolidated Net Income/Loss |
$6.96M |
$6.96M |
|
$13.87M |
|
$23.66M |
|
18.40M |
|
18.41M |
|
$0.41 |
|
$0.41 |
|
| Balance Sheet Financials | |
$294.23M |
|
$94.62M |
|
$444.73M |
|
$738.97M |
|
$117.24M |
|
-- |
|
$78.18M |
|
$195.42M |
|
$543.55M |
|
$276.52M |
|
$543.55M |
|
18.46M |
|
| Cash Flow Statement Financials | |
$9.76M |
|
$-2.60M |
|
$-3.64M |
|
$161.24M |
|
$165.66M |
|
$4.42M |
|
$3.45M |
|
$-1.38M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.51 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
76.25% |
|
5.54% |
|
5.54% |
|
-- |
|
6.18% |
|
3.00% |
|
$7.16M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
0.62 |
|
25.91 |
|
3.47 |
|
1.28% |
|
2.52% |
|
0.94% |
|
1.28% |
|
$29.45 |
|
$0.39 |
|
$0.53 |
|